Morgan Stanley’s Avita Medical RCEL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.18M | Buy |
222,193
+134,180
| +152% | +$710K | ﹤0.01% | 5018 |
|
|
2025
Q1 | $716K | Buy |
88,013
+3,097
| +4% | +$25.2K | ﹤0.01% | 5163 |
|
|
2024
Q4 | $1.09M | Sell |
84,916
-12,497
| -13% | -$160K | ﹤0.01% | 5044 |
|
|
2024
Q3 | $1.04M | Sell |
97,413
-11,219
| -10% | -$120K | ﹤0.01% | 5021 |
|
|
2024
Q2 | $860K | Buy |
108,632
+68,816
| +173% | +$545K | ﹤0.01% | 5051 |
|
|
2024
Q1 | $638K | Sell |
39,816
-84,780
| -68% | -$1.36M | ﹤0.01% | 5201 |
|
|
2023
Q4 | $1.71M | Sell |
124,596
-34,016
| -21% | -$467K | ﹤0.01% | 5007 |
|
|
2023
Q3 | $2.32M | Buy |
158,612
+122,565
| +340% | +$1.79M | ﹤0.01% | 4291 |
|
|
2023
Q2 | $613K | Sell |
36,047
-20,674
| -36% | -$352K | ﹤0.01% | 5116 |
|
|
2023
Q1 | $792K | Buy |
56,721
+38,863
| +218% | +$543K | ﹤0.01% | 4993 |
|
|
2022
Q4 | $118K | Sell |
17,858
-12,591
| -41% | -$83.1K | ﹤0.01% | 5907 |
|
|
2022
Q3 | $161K | Sell |
30,449
-37,077
| -55% | -$196K | ﹤0.01% | 5830 |
|
|
2022
Q2 | $320K | Buy |
67,526
+32,654
| +94% | +$155K | ﹤0.01% | 5647 |
|
|
2022
Q1 | $296K | Buy |
34,872
+2,014
| +6% | +$17.1K | ﹤0.01% | 5704 |
|
|
2021
Q4 | $393K | Buy |
32,858
+4,282
| +15% | +$51.2K | ﹤0.01% | 5691 |
|
|
2021
Q3 | $506K | Sell |
28,576
-9,811
| -26% | -$174K | ﹤0.01% | 5492 |
|
|
2021
Q2 | $788K | Buy |
38,387
+24,407
| +175% | +$501K | ﹤0.01% | 5224 |
|
|
2021
Q1 | $277K | Buy |
13,980
+553
| +4% | +$11K | ﹤0.01% | 5472 |
|
|
2020
Q4 | $249K | Sell |
13,427
-230
| -2% | -$4.27K | ﹤0.01% | 5481 |
|
|
2020
Q3 | $344K | Sell |
13,657
-1,155
| -8% | -$29.1K | ﹤0.01% | 4830 |
|
|
2020
Q2 | $452K | Sell |
14,812
-560
| -4% | -$17.1K | ﹤0.01% | 4651 |
|
|
2020
Q1 | $477K | Sell |
15,372
-788
| -5% | -$24.5K | ﹤0.01% | 4398 |
|
|
2019
Q4 | $735K | Buy |
+16,160
| New | +$735K | ﹤0.01% | 4718 |
|